PMID- 26769066 OWN - NLM STAT- MEDLINE DCOM- 20180126 LR - 20220316 IS - 1477-0970 (Electronic) IS - 1352-4585 (Print) IS - 1352-4585 (Linking) VI - 22 IP - 12 DP - 2016 Oct TI - Genetic predictors of relapse rate in pediatric MS. PG - 1528-1535 AB - BACKGROUND: Genetic ancestry, sex, and individual alleles have been associated with multiple sclerosis (MS) susceptibility. OBJECTIVE: To determine whether established risk factors for disease onset are associated with relapse rate in pediatric MS. METHODS: Whole-genome genotyping was performed for 181 MS or high-risk clinically isolated syndrome patients from two pediatric MS centers. Relapses and disease-modifying therapies were recorded as part of continued follow-up. Participants were characterized for 25-hydroxyvitamin D serum status. Ancestral estimates (STRUCTURE v2.3.1), human leukocyte antigen (HLA)-DRB1*15 carrier status (direct sequencing), sex, and a genetic risk score (GRS) of 110 non-HLA susceptibility single-nucleotide polymorphisms (SNPs) were evaluated for association with relapse rate with Cox and negative binomial regression models. RESULTS: Over 622 patient-years, 408 relapses were captured. Girls had greater relapse rate than boys (incident rate ratio (IRR) = 1.40, 95% confidence interval (CI) = 1.04-1.87, p = 0.026). Participants were genetically diverse; ~40% (N = 75) had <50% European ancestry. HLA-DRB1*15 status modified the association of vitamin D status (p(ixn) = 0.022) with relapse rate (per 10 ng/mL, in DRB1*15+ hazard ratio (HR) = 0.72, 95% CI = 0.58-0.88, p = 0.002; in DRB1*15- HR = 0.96, 95% CI = 0.83-1.12, p = 0.64). Neither European ancestry nor GRS was associated with relapse rate. CONCLUSION: We demonstrate that HLA-DRB1*15 modifies the association of vitamin D status with relapse rate. Our findings emphasize the need to pursue disease-modifying effects of MS genes in the context of environmental factors. CI - (c) The Author(s), 2016. FAU - Graves, Jennifer S AU - Graves JS AD - UCSF Pediatric Multiple Sclerosis Center, San Francisco, CA, USA Jennifer.Graves@ucsf.edu. FAU - Barcellos, Lisa F AU - Barcellos LF AD - Genetic Epidemiology and Genomics Lab, School of Public Health, and California Institute for Quantitative Biosciences, University of California-Berkeley, Berkeley, CA, USA. FAU - Shao, Xiaorong AU - Shao X AD - Genetic Epidemiology and Genomics Lab, School of Public Health, and California Institute for Quantitative Biosciences, University of California-Berkeley, Berkeley, CA, USA. FAU - Noble, Janelle AU - Noble J AD - Children's Hospital Oakland Research Institute, Oakland, CA, USA. FAU - Mowry, Ellen M AU - Mowry EM AD - The Multiple Sclerosis Center, Johns Hopkins University, Baltimore, MD, USA. FAU - Quach, Hong AU - Quach H AD - Genetic Epidemiology and Genomics Lab, School of Public Health, and California Institute for Quantitative Biosciences, University of California-Berkeley, Berkeley, CA, USA. FAU - Belman, Anita AU - Belman A AD - National Pediatric Multiple Sclerosis Center, Stony Brook, NY, USA. FAU - Casper, T Charles AU - Casper TC AD - Data Coordinating and Analysis Center, University of Utah, Salt Lake City, UT, USA. FAU - Krupp, Lauren B AU - Krupp LB AD - National Pediatric Multiple Sclerosis Center, Stony Brook, NY, USA. FAU - Waubant, Emmanuelle AU - Waubant E AD - UCSF Pediatric Multiple Sclerosis Center, San Francisco, CA, USA. CN - U.S. Network of Pediatric MS Centers LA - eng GR - R01 NS071463/NS/NINDS NIH HHS/United States GR - K12 HD052163/HD/NICHD NIH HHS/United States GR - R01 AI076544/AI/NIAID NIH HHS/United States GR - R01 NS049510/NS/NINDS NIH HHS/United States GR - R01 ES017080/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20160114 PL - England TA - Mult Scler JT - Multiple sclerosis (Houndmills, Basingstoke, England) JID - 9509185 RN - 0 (HLA-DRB1 Chains) RN - 0 (HLA-DRB1*15 antigen) RN - FXC9231JVH (Calcitriol) SB - IM MH - Adolescent MH - Age of Onset MH - Calcitriol/*blood MH - Child MH - Female MH - Follow-Up Studies MH - Genotyping Techniques MH - HLA-DRB1 Chains/*genetics MH - Humans MH - Male MH - Multiple Sclerosis/*blood/*genetics/*physiopathology MH - Recurrence MH - Sex Factors PMC - PMC4945462 MID - NIHMS743331 OTO - NOTNLM OT - Genetics OT - multiple sclerosis OT - outcome measurement OT - relapsing/remitting OT - vitamin D EDAT- 2016/01/16 06:00 MHDA- 2018/01/27 06:00 PMCR- 2017/10/01 CRDT- 2016/01/16 06:00 PHST- 2015/07/22 00:00 [received] PHST- 2015/11/25 00:00 [accepted] PHST- 2016/01/16 06:00 [pubmed] PHST- 2018/01/27 06:00 [medline] PHST- 2016/01/16 06:00 [entrez] PHST- 2017/10/01 00:00 [pmc-release] AID - 1352458515624269 [pii] AID - 10.1177/1352458515624269 [doi] PST - ppublish SO - Mult Scler. 2016 Oct;22(12):1528-1535. doi: 10.1177/1352458515624269. Epub 2016 Jan 14.